Nausea is the single most common complaint, affecting a significant percentage of users especially during dose escalation
Injectable GLP-1s have cash-pay pricing starting at $299 per month
This was accompanied by upregulation of FABP4 and HSL , alongside reduced receptor for advanced glycation end products ( RAGE ) expression, suggesting enhanced lipid turnover and improved adipocyte function
Real-world cases and clinical guidance show that such measures make a big difference in comfort levels for IBS patients on GLP-1 therapy
Furthermore, a substantial proportion of cases involving the other nine AEDs were found to be in conjunction with VPA
Short-acting GLP-1RAs, such as exenatide and lixisenatide, have a half-life of 24 h, requiring daily administration once or twice a day